Career Development @ Break for Career Development (January 2019 - August 2019)
Project Leader @ (January 2013 - December 2018)
Post Doc @ (January 2010 - January 2013)
Consultant @ (December 2017 - January 2018)
Visiting Scholar @ (November 2016 - April 2017)
Visiting Scholar @ (October 2015 - December 2015)
Research Associate @ (October 2004 - December 2005)
Pedro Teixeira Education
Stockholm University
PhD (Biochemistry)
2006-2009
Universidade do Porto
Bachelor's degree (Biochemistry)
2000-2004
Pedro Teixeira Skills
Amyloid diseases
Artificial Intelligence (AI)
Biochemistry
Biotechnology
Brand Development
Business Development
Cell Biology
Cell Culture
Clinical Affairs
Clinical Development
Clinical Research Experience
Clinical Trials
Competitive Intelligence
Data Analysis
Diabetes
Drug Development
Experimental Design
Good Clinical Practice (GCP)
Grant Preparation
Grant Writing
Healthcare Management
Integrative biology
Leadership
Marketing
Medical Affairs
Medical Education
Mitochondrial diseases
Molecular Biology
Organization Skills
PCR
Plant science
Presentations
Program Management
Project Management
Proteases
Protein Chemistry
Protein Expression
Protein Purification
Purification
Rare Diseases
Regulatory Affairs
Regulatory Compliance
Research Funding
Science Communication
Scientific Communications
Scientific Writing in English
Strategic Partnerships
Strategic Planning
Supervisory Skills
Pedro Teixeira Summary
Pedro Teixeira, based in Stockholm, SE, is currently a Director Medical Affairs at Diamyd Medical. Pedro Teixeira brings experience from previous roles at Diamyd Medical, ASSET - Industry/Healthcare Strategic Partnership (VINNOVA-funded Precision Hea and Break for Career Development. Pedro Teixeira holds a 2006 - 2009 PhD in Biochemistry @ Stockholm University. With a robust skill set that includes Amyloid diseases, Artificial Intelligence (AI), Biochemistry, Biotechnology, Brand Development and more. Pedro Teixeira has 3 emails on RocketReach.
Looking for a different Pedro Teixeira?
Find contact details for 700 million professionals.